Oppenheimer Reiterates Outperform on Athenahealth (ATHN) Following 2017 Guidance
Tweet Send to a Friend
Oppenheimer reiterated an Outperform rating and $144.00 price target on athenahealth (NASDAQ: ATHN) following the company's 2017 guidance, ahead of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
